Search

everythinglearnresearchcommunity

for

Search:↓

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Finasteride may improve prostate cancer treatment outcomes.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Plant compounds may help manage PCOS, endometriosis, and menstrual issues.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

DHT, a testosterone byproduct, causes male pattern baldness.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Some supplements and hormones can increase hair loss by raising DHT levels.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Neurosteroids regulate synaptic inhibition in the spinal cord and may help manage spinal pain.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

SHBG may be a useful early indicator and treatment target for PCOS.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.